BGB-3111 gets a name - zanubrutinib - CLL Support
BGB-3111 gets a name - zanubrutinib
Written by
avzuclav
To view profiles and participate in discussions please or .
1 Reply
•
Very interesting. It appears that zanubrutinib is shaping up to be a superior form of ibrutinib. Less toxicity and tighter targeting. The company, BeiGene, is Chinese, but they are making a real competitor for ibrutinib. We are getting more options everyday!
Ibrutinib, Acalabrutinib, or Zanubrutinib 
Zanubrutinib to be considered by UK NICE
Acalabrutinib v Zanubrutinib side effects
